00401.HK
Wanjia Group Holdings Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.11
+0.96%Year over year
Reported trailing growth
- Revenue
- +2.3%
- EBITDA
- —
- EBIT
- -21.6%
- EPS
- -0.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.6%
- EBITDA
- —
- EBIT
- -78.3%
- Net income
- -49.1%
- EPS
- -16.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026